Seller record · Telehealth service

Gimme Care

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The pages say medication ships from a licensed US pharmacy and the terms refer to a pharmacy network, and no pharmacy is named in the footer, the terms, the privacy policy or the shipping policy. 1 more criterion also fails; see the table below.

At a glance

Gimme CareTelehealth service

6/8criteria passed

Price: Semaglutide from $130 a month, tirzepatide from $163
Sells: compounded semaglutide, compounded tirzepatide, sermorelin injection, and 6 more
FDA letters: None on file

Visit Gimme Care See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide, sermorelin, NAD+ and glutathione injections and vitamin shots, with one-month and three-month prices on each product page. Care is provided through a named telehealth group, and no filling pharmacy is named.

Operating entity Start Gimme, LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Gimme Care's compounded semaglutide product page; Gimme Care's terms of service page
S2	Prescription gating	PASS	Gimme Care's intro page on its intake site; Gimme Care's sermorelin page on its get site
S3	Pharmacy identification	FAIL	Gimme Care's website; Gimme Care's terms of service page; Gimme Care's shipping page
S4	Compounding disclosure	PASS	Gimme Care's website; Gimme Care's compounded semaglutide product page
S5	Analytical documentation	FAIL	Gimme Care's website; Gimme Care's about page
S6	Business address	PASS	Gimme Care's terms of service page; Gimme Care's about page
S7	Price disclosure	PASS	Gimme Care's website; Gimme Care's compounded semaglutide product page; Gimme Care's sermorelin product page; Gimme Care's NAD+ glutathione bundle product page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed healthcare provider reviews each medical questionnaire and prescribes only if treatment is medically appropriate, and the terms say care is provided through Bask Telehealth LLC.Source: Gimme Care's compounded semaglutide product page; Gimme Care's terms of service page.

S2PASSThe start button opens a weight loss questionnaire whose first screen asks the buyer's weight loss goal, and the sermorelin button opens a questionnaire asking the buyer's health goals.Source: Gimme Care's intro page on its intake site; Gimme Care's sermorelin page on its get site.

S3FAILThe pages say medication ships from a licensed US pharmacy and the terms refer to a pharmacy network, and no pharmacy is named in the footer, the terms, the privacy policy or the shipping policy.Source: Gimme Care's website; Gimme Care's terms of service page; Gimme Care's shipping page.

S4PASSThe footer on every page states that the compounded medications are not approved by FDA, and the semaglutide page states beside the price that compounded medications are not FDA-approved.Source: Gimme Care's website; Gimme Care's compounded semaglutide product page.

S5FAILNo certificate of analysis or lot document is published on the product pages, the about page or the policies.Source: Gimme Care's website; Gimme Care's about page.

S6PASSStart Gimme, LLC at 251 Little Falls Drive, Wilmington, DE 19808, printed in the terms as its address and on the about page as its headquarters.Source: Gimme Care's terms of service page; Gimme Care's about page.

S7PASSCompounded semaglutide at $160 a month, or $130 a month on a 3-month plan, and compounded tirzepatide at $199 a month, or $163 a month on a 3-month plan, the same price at every dose. Sermorelin at $129 a month for 9 mg, or $189 a month for 15 mg and $179 a month on a 3-month plan. The NAD+ injection at $129 a month or $99 on 3 months, glutathione at $99 or $63, and the NAD+ and glutathione bundle at $189 or $135.Source: Gimme Care's website; Gimme Care's compounded semaglutide product page; Gimme Care's sermorelin product page; Gimme Care's NAD+ glutathione bundle product page.

S8PASSNo FDA warning letter names Gimme Care or Start Gimme, LLC, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin injection, NAD+ injection, glutathione injection, NAD+ and glutathione bundle, MIC+B12, cyanocobalamin (B12), ondansetron.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Gimme Care

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.